Self-expanding wallstent endoprosthesis for malignant ureteral obstruction.
We present our experience with the self-expanding Wallstent endoprosthesis for ureteral recanalization in obstructive uropathy secondary to malignant pelvic disease. In total, 19 stents were inserted in 14 ureters. The follow-up included 100% of the patients. To date, except for one case, the patency of the stent has always persisted for the period of the survival of the patients, the longest ones being 4 and 4.1 years.
Díaz-Lucas
E F
EF
Department of Radiology, San Cecilio University Hospital, Faculty of Medicine, Granada, Spain.
Martínez-Torres
J L
JL
Fernández Mena
J
J
Carazo Martínez
O
O
de la Fuente Serrano
A
A
Zuluaga Gómez
A
A
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous / Q000295:instrumentation / Q000379:methods*; D010386:Pelvic Neoplasms / Q000150:complications* / Q000401:mortality; D019919:Prosthesis Implantation; D012189:Retrospective Studies; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome; D014517:Ureteral Obstruction / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*